BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 956340)

  • 41. Abnormalities in circadian patterns of bone resorption and renal calcium conservation in type I osteoporosis.
    Eastell R; Calvo MS; Burritt MF; Offord KP; Russell RG; Riggs BL
    J Clin Endocrinol Metab; 1992 Mar; 74(3):487-94. PubMed ID: 1740481
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Uninterrupted oral bisphosphonate (pamidronate) therapy of patients with osteoporosis is not associated with chronic stimulation of parathyroid hormone secretion.
    Landman JO; Papapoulos SE
    Osteoporos Int; 1995 Mar; 5(2):93-6. PubMed ID: 7599454
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Formation, mineralization, and resorption of bone in hypophosphatemic rats.
    Baylink D; Wergedal J; Stauffer M
    J Clin Invest; 1971 Dec; 50(12):2519-30. PubMed ID: 5129305
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.
    Uretmen S; Gol M; Cimrin D; Irmak E
    Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):67-71. PubMed ID: 16051419
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New approaches to the problems of osteoporosis.
    Nordin BE; Need AG; Morris HA; Horowitz M
    Clin Orthop Relat Res; 1985 Nov; (200):181-97. PubMed ID: 3905110
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Histological studies of bone from normocalcemic post-menopausal osteoporotic patients with increased circulating parathyroid hormone.
    Teitelbaum SL; Rosenberg EM; Richardson CA; Avioli LV
    J Clin Endocrinol Metab; 1976 Mar; 42(3):537-43. PubMed ID: 1254694
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anabolic effect of low doses of a fragment of human parathyroid hormone on the skeleton in postmenopausal osteoporosis.
    Reeve J; Hesp R; Williams D; Hulme P; Klenerman L; Zanelli JM; Darby AJ; Tregear GW; Parsons JA
    Lancet; 1976 May; 1(7968):1035-8. PubMed ID: 57447
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The action of 1alphahydroxy vitamin D3 and phosphate supplements in hypophosphataemic osteomalacia.
    Peacock M; Aaron JE; Heyburn PJ; Nordin BE
    Adv Exp Med Biol; 1977; 81():431-40. PubMed ID: 899935
    [No Abstract]   [Full Text] [Related]  

  • 49. Bone histomorphometry in hypogonadal and eugonadal men with spinal osteoporosis.
    Jackson JA; Kleerekoper M; Parfitt AM; Rao DS; Villanueva AR; Frame B
    J Clin Endocrinol Metab; 1987 Jul; 65(1):53-8. PubMed ID: 3584399
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vitamin D metabolism and the response to 1,25-dihydroxycholecalciferol in Osteoporosis.
    Davies M; Mawer EB; Adams PH
    J Clin Endocrinol Metab; 1977 Aug; 45(2):199-208. PubMed ID: 195972
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative response to parathyroid hormone in hyperthyroidism and hypothyroidism.
    Castro JH; Genuth SM; Klein L
    Metabolism; 1975 Jul; 24(7):839-48. PubMed ID: 1138158
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects of sodium fluoride, calcium phosphate, and vitamin D2 for one to two years on calcium and phosphorus metabolism in postmenopausal women with spinal crush fracture osteoporosis.
    Charles P; Mosekilde L; Jensen FT
    Bone; 1985; 6(4):201-6. PubMed ID: 3876838
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanisms underlying the effects of phosphate and calcitonin on bone histology in postmenopausal osteoporosis.
    Marie PJ; Caulin F
    Bone; 1986; 7(1):17-22. PubMed ID: 3964494
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of mineral metabolism and bone turnover in osteoporotic females treated with phosphorus and salmon calcitonin.
    Cantatore FP; Carrozzo M; Magli DM; D'Amore M; Pipitone V
    Clin Rheumatol; 1987 Dec; 6(4):504-9. PubMed ID: 3502402
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of transdermal oestrogen on bone, calcium-regulating hormones and liver in postmenopausal women.
    Selby PL; Peacock M
    Clin Endocrinol (Oxf); 1986 Nov; 25(5):543-7. PubMed ID: 3113780
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of nandrolone decanoate on forearm mineral density and calcium metabolism in osteoporotic postmenopausal women.
    Need AG; Morris HA; Hartley TF; Horowitz M; Nordin BE
    Calcif Tissue Int; 1987 Jul; 41(1):7-10. PubMed ID: 3113703
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bone loss in premenopausal and postmenopausal women. A cross-sectional and longitudinal study using quantitative computed tomography.
    Ruegsegger P; Dambacher MA; Ruegsegger E; Fischer JA; Anliker M
    J Bone Joint Surg Am; 1984 Sep; 66(7):1015-23. PubMed ID: 6332808
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The relation between bone loss and calcium balance in women.
    Horsman A; Marshall DH; Nordin BE; Crilly RG; Simpson M
    Clin Sci (Lond); 1980 Aug; 59(2):137-42. PubMed ID: 7408419
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of NaCl on calcium balance, parathyroid function and hydroxyproline excretion in prednisolone-treated rats consuming low calcium diet.
    Goulding A; McIntosh J
    J Nutr; 1986 Jun; 116(6):1037-44. PubMed ID: 3014091
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increase in serum bone gamma-carboxyglutamic acid protein with aging in women. Implications for the mechanism of age-related bone loss.
    Delmas PD; Stenner D; Wahner HW; Mann KG; Riggs BL
    J Clin Invest; 1983 May; 71(5):1316-21. PubMed ID: 6304145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.